Post-transplant lymphoproliferative diseases (PTLD) are heterogeneous lymphoid disorders
ranging from indolent polyclonal proliferations to aggressive lymphomas that complicate …

Post-transplant lymphoproliferative disorders (PTLDs) are a group of conditions that involve
uncontrolled proliferation of lymphoid cells as a consequence of extrinsic …

Purpose Adult post-transplantation lymphoproliferative disease (PTLD) has a reported 3-
year overall survival (OS) of 35% to 40%. The impact of rituximab on the outcome of PTLD is …

Reduction of immunosuppression (RI) is commonly used to treat posttransplant
lymphoproliferative disorder (PTLD) in solid organ transplant recipients. We investigated the …

Post-transplant lymphoproliferative disorders (PTLD) are a rare but serious complication
after organ transplantation. A French Registry of PTLD was set up in a nationwide …

We performed a multicenter, International analysis of solid organ transplant (SOT)-related
primary central nervous system (PCNS) posttransplant lymphoproliferative disease (PTLD) …

A higher risk for a variety of cancers is among the major complications of posttransplantation
immunosuppression. In this part of a continuing series on cancers posttransplantation, this …

Viruses are among the most common causes of opportunistic infection after transplantation.
The risk for viral infection is a function of the specific virus encountered, the intensity of …

Viral infections remain a significant cause of morbidity and mortality following renal
transplantation. Although cytomegalovirus is the most common opportunistic pathogen seen …

Purpose Post-transplantation lymphoproliferative disorder (PTLD) is associated with
significant mortality in kidney transplant recipients. We conducted a prospective survey of …